Print

Jonathan Kimball takes over the position of IGBA Chair (January 2023)

The International Generic and Biosimilar Medicines Association (IGBA), representing global manufacturers of generic and biosimilar medicines, announced today that Jonathan Kimball, Vice President of Trade and International Affairs of the Association for Accessible Medicines (AAM), Vice-Chair IGBA and Vice Chair of the IGBA International Trade and Intellectual Property Committee in 2022, is taking over the position of IGBA Chair for 2023 from Vivian Frittelli, Chief Executive of Generic and Biosimilar Medicines of Southern Africa (GBM). Adrian van den Hoven, Director General of Medicines for Europe, steps in as IGBA Vice-Chair.

Read More

 

Share this page!

Contact Info

IGBA | INTERNATIONAL GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION

C/O DYN SA
Rue de Cornavin 11
1201 Geneva, Switzerland

E-mail: 
This email address is being protected from spambots. You need JavaScript enabled to view it.  

Follow us on: Twitter - LinkedIn - YouTube

We use cookies to improve our website and your experience when using it. Cookies used for the essential operation of the site have already been set. To find out more about the cookies we use and how to delete them, see our Privacy Policy.

I accept cookies from this site